SINT Stock Analysis: Buy, Sell, or Hold?
SINT - SiNtx Technologies, Inc. Common Stock
$2.27
-0.13 (-5.62%)
▼
5d:
-3.62%
30d:
-15.49%
90d:
-25.37%
BUY
HIGH Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 21, 2026
2d
Get Alerted When SINT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SINT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SINT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: SINT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: SINT is currently trading at $2.27, which is considered oversold relative to its 30-day fair value range of $2.27 to $2.70.
Technical Outlook: Technically, SINT is in a strong downtrend. The price is currently testing key support at $2.28. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.17 (+348.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SINT is in a strong downtrend. The price is currently testing key support at $2.28. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.17 (+348.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.27 -
$2.70
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.6%)
- BULLISH: Trading 348.9% below Wall St target ($10.17)
Trading Range Analysis
30-Day Trading Range
$2.27 -
$2.70
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.28
Resistance Level
$2.64
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.29
Wall Street Target
$10.17
(+348.9%)
Revenue Growth (YoY)
-46.5%
Share & Embed Analysis
Last updated: May 18, 2026 6:48 AM ET
Data refreshes hourly during market hours. Next update: 7:48 AM
Data refreshes hourly during market hours. Next update: 7:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SINT showing a specific setup today?
Insider Activity (6 Months)
6
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Christopher Michael Lyons
BUY
7534 shares
2026-03-02
Christopher Michael Lyons
BUY
758 shares
2026-02-25
Jay M Moyes
BUY
1000 shares
2026-02-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
